Entity Common Stock, Shares Outstanding of 4D Molecular Therapeutics, Inc. from 15 Mar 2021 to 23 Feb 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
4D Molecular Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 15 Mar 2021 to 23 Feb 2024.
  • 4D Molecular Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 23 Feb 2024 was 49,778,127, a 50% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

4D Molecular Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 49,778,127 +16,543,770 +50% 23 Feb 2024 10-K 29 Feb 2024 2023 FY
Q3 2023 42,753,607 +10,361,229 +32% 02 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 42,052,980 +9,670,602 +30% 04 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 33,234,357 +996,861 +3.1% 08 Mar 2023 10-K 15 Mar 2023 2022 FY
Q3 2022 32,392,378 +253,564 +0.79% 02 Nov 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 32,382,378 +5,394,123 +20% 08 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 32,237,496 +5,544,617 +21% 28 Mar 2022 10-K 28 Mar 2022 2021 FY
Q3 2021 32,138,814 10 Nov 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 26,988,255 05 Aug 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 26,692,879 15 Mar 2021 10-K 25 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.